SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-027449
Filing Date
2023-08-10
Accepted
2023-08-10 08:05:24
Documents
16
Period of Report
2023-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 34172
2 ex16-1.htm EX-16.1 4252
3 ex99-1.htm EX-99.1 103413
4 ex99-1_001.jpg GRAPHIC 3612
5 ex99-1_002.jpg GRAPHIC 112806
  Complete submission text file 0001493152-23-027449.txt   492995

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dare-20230810.xsd EX-101.SCH 3033
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dare-20230810_lab.xml EX-101.LAB 34240
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dare-20230810_pre.xml EX-101.PRE 22371
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3290
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 231157259
SIC: 2834 Pharmaceutical Preparations